Skip to main content

4 Result(s)

within Preeti Diwaker Remove this filter

and

  1. No Access

    Article

    Expression of Immune Checkpoint Regulator Cytotoxic T Lymphocyte Antigen 4 (CTLA-4) and Programmed Cell Death Protein Ligand 1 (PD-L1) in Invasive Ductal Carcinoma Breast

    Despite significant advancement in the diagnostic and therapeutic aspects of breast carcinoma, the prognosis remains dismal. Recently, with advances in its understanding, various immune system-based management...

    Preeti Diwaker, Tanvi Jha, Priyanka Gogoi… in Indian Journal of Surgical Oncology (2024)

  2. Article

    Prognostic Value of IMP3 and Its Role as an Epithelial-Mesenchymal Transition Promoter in Breast Carcinoma

    Breast carcinoma is now the most common cancer in the world. In view of its high mortality, there is a need to identify new prognostic biomarkers. Both IMP3 and SLUG have been implicated in cancer metastasis. ...

    Tanvi Jha, Preeti Diwaker, Vinod Kumar Arora… in Indian Journal of Surgical Oncology (2023)

    Download PDF (1324 KB) View Article

  3. No Access

    Article

    Endometrial Stromal Sarcoma: Case Series with Emphasis on Gross Features

    Gunjan Mangla, Preeti Diwaker, Priyanka Gogoi in Indian Journal of Surgical Oncology (2019)

  4. No Access

    Article

    Low-Grade Central Osteosarcoma: Report of Two Unusual Morphologic Variants

    Low-grade central osteosarcoma (LGCO) is a rare subtype of osteosarcoma, constituting < 2% of all osteosarcomas. If not treated appropriately, the tumor can recur with higher-grade disease. We report two cases...

    Neha Chopra Narang, Preeti Diwaker, Salil Narang… in Indian Journal of Surgical Oncology (2018)